Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$12.21 - $16.99 $399,108 - $555,352
-32,687 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$9.03 - $19.72 $5,734 - $12,522
635 Added 1.98%
32,687 $437,000
Q4 2019

Feb 13, 2020

BUY
$13.01 - $17.15 $7,428 - $9,792
571 Added 1.81%
32,052 $452,000
Q3 2019

Nov 13, 2019

SELL
$14.55 - $20.56 $657,165 - $928,612
-45,166 Reduced 58.93%
31,481 $514,000
Q2 2019

Aug 08, 2019

BUY
$15.0 - $19.62 $24,045 - $31,450
1,603 Added 2.14%
76,647 $1.2 Million
Q1 2019

May 13, 2019

BUY
$11.65 - $17.72 $7,922 - $12,049
680 Added 0.91%
75,044 $1.3 Million
Q4 2018

Feb 14, 2019

BUY
$10.72 - $16.73 $5,885 - $9,184
549 Added 0.74%
74,364 $828,000
Q3 2018

Nov 13, 2018

BUY
$17.73 - $26.69 $171,874 - $258,732
9,694 Added 15.12%
73,815 $1.8 Million
Q2 2018

Aug 13, 2018

SELL
$10.79 - $24.44 $1,780 - $4,032
-165 Reduced 0.26%
64,121 $1.16 Million
Q1 2018

May 14, 2018

SELL
$9.0 - $20.16 $20,268 - $45,400
-2,252 Reduced 3.38%
64,286 $718,000
Q4 2017

Feb 13, 2018

SELL
$13.26 - $22.86 $644,780 - $1.11 Million
-48,626 Reduced 42.22%
66,538 $1.29 Million
Q3 2017

Nov 13, 2017

BUY
$19.76 - $24.9 $23,632 - $29,780
1,196 Added 1.05%
115,164 $2.49 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-2,353 Reduced 2.02%
113,968 $2.27 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-607 Reduced 0.52%
116,321 $1.76 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-11,248 Reduced 8.78%
116,928 $1.16 Million
Q3 2016

Apr 17, 2019

BUY
N/A
128,176
128,176 $1.43 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $684M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.